Orthopediatrics Corp. (KIDS) stock forecast and price target
Price $32.35 · data as of November 13, 2026
12-month price target
Gold marker: average target · white marker: today’s price ($32.35)
Analyst ratings
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends December 31, 2026 | $-1.09 | −9.2% | $272M |
| Next fiscal year ends December 31, 2027 | $-0.75 | +31.0% | $304M |
| Next quarter ends December 31, 2026 | $-0.20 | +22.3% | $69M |
| Quarter after ends March 31, 2027 | $-0.30 | +28.6% | $67M |
Consensus of the analysts covering Orthopediatrics, updated daily. In the last 30 days 2 estimates were raised and 2 lowered.
Our model vs. Wall Street
Analysts see 4.9% downside over 12 months. Our discounted cash flow model with moderate assumptions puts Orthopediatrics’s intrinsic value about 84% below today’s market value, and it scores 1.2 out of 5 on our checks. Price targets follow sentiment; a DCF follows cash. When both point the same way the signal is stronger. Try your own assumptions.
Frequently asked questions
What is the Orthopediatrics stock price target?
The average 12-month target from 8 analysts is $30.75, 4.9% below the current price of $32.35 Targets range from $27.00 to $38.00.
Is Orthopediatrics a buy according to analysts?
The consensus rating is “None” (2 strong buy, 4 buy, 1 hold). Ratings are opinions, not guarantees; this is not investment advice.
How much is Orthopediatrics expected to earn?
Analysts expect EPS of $-1.09 for the fiscal year ending December 31, 2026 and $-0.75 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.